ISIS 14803-CS2

ISIS 14803 · Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS 14803-CS2, covering 2022-12-05 to 2022-12-05. Get the full timeline:

Most recent: Clinical Trial Update: ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections [Phase 2]

See pricing